Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies.
about
Bias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation CarriersTumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography.Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment.Genetic testing in women with breast cancer: implications for treatment.BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population.
P2860
Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Long-term prospective clinical ...... djusted retrospective studies.
@en
Long-term prospective clinical ...... djusted retrospective studies.
@nl
type
label
Long-term prospective clinical ...... djusted retrospective studies.
@en
Long-term prospective clinical ...... djusted retrospective studies.
@nl
prefLabel
Long-term prospective clinical ...... djusted retrospective studies.
@en
Long-term prospective clinical ...... djusted retrospective studies.
@nl
P2860
P50
P1476
Long-term prospective clinical ...... djusted retrospective studies.
@en
P2093
Fiona Lalloo
P2860
P304
P356
10.1136/JMEDGENET-2014-102336
P407
P577
2014-07-22T00:00:00Z